The Food and Drug Administration (FDA) recently approved Keytruda (pembrolizumab) plus chemoradiotherapy (CRT) for the treatment of patients with stages 3 to 4A cervical cancer. The first approval of ...

Merck (NYSE:MRK) received FDA approval for expanded use of KEYTRUDA and KEYTRUDA QLEX with WELIREG as adjuvant treatment in ...

Keytruda is a prescription drug that’s given as an intravenous (IV) infusion (and injection into a vein over a period of time). Learn about how the drug is given, how often you’ll receive doses, and ...

Keytruda is an immunotherapy drug that is used to treat different types of cancers. The drug helps the body's own immune system to fight the cancer cells. Developed and sold by Merck & Co., the drug ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

KEYLYNK-008 marks another setback for Merck’s plan to combine Keytruda and Lynparza together. (Photo by Kena Betancur/Getty Images) Merck has called it quits on another attempt to enhance its powerful ...

While an ovarian cancer trial of the Keytruda-Lynparza combination met its primary endpoint, Merck said that the role of Keytruda in the indication "remains uncertain at this time." (Merck & Co.) ...

A recent cross-border investigation examines how aggressive drug pricing and patent strategies drive up costs and limit ...